STOCK TITAN

Schedule 13G: Citadel Entities Disclose 5.3% Combined ETHZ Stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Citadel-linked entities disclosed shared beneficial ownership of ETHZilla Corporation common stock totaling 5,643,440 shares, representing 3.5% of the outstanding class, as of the opening of trading on September 25, 2025. The Schedule 13G is jointly filed by Citadel Securities GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC, and Kenneth Griffin. Citadel Advisors-related entities report beneficial ownership of 2,774,758 shares (1.7%).

Mr. Kenneth Griffin is reported with shared beneficial ownership of 8,418,198 shares, equal to 5.3% of the class. The filing states the share count is based on 160,176,168 Shares outstanding, which includes 46 Shares issuable on conversion of certain warrants held by affiliates. Signatures are dated September 25, 2025.

Positive

  • Transparent disclosure of aggregated beneficial ownership by multiple Citadel entities and Kenneth Griffin, including exact share counts and percentages.
  • Certification of passive intent states the holdings were not acquired to influence control, which clarifies the nature of the positions for investors.

Negative

  • None.

Insights

TL;DR: Citadel entities and Kenneth Griffin disclosed passive, shared holdings in ETHZilla totaling up to 5.3% for Griffin; filing signals institutional stake monitoring.

The Schedule 13G reports shared voting and dispositive power rather than sole control, and contains explicit percentages tied to a 160,176,168 share base. The largest reported shared stake among the corporate filers is 5,643,440 shares (3.5%), while the advisory/affiliate path shows 2,774,758 shares (1.7%). Mr. Griffin's aggregated shared position of 8,418,198 shares (5.3%) crosses the 5% threshold that typically requires public disclosure, explaining this filing. The certification clarifies the holdings are not intended to influence control of the issuer. For investors, this provides transparent ownership disclosure without indication of an active control campaign.

TL;DR: Filing documents joint reporting structure and clarifies relationships among Citadel entities and Kenneth Griffin; no governance change implied.

The Schedule delineates organizational roles: Citadel Advisors as portfolio manager for the Cayman fund, CALC4 as non-member manager of Citadel Securities, and CSGP/CGP as general partners, with Mr. Griffin holding controlling interests in GP entities. All reporting persons state shared voting and dispositive powers, and the certifications assert passive intent. The filing includes a joint filing agreement (Exhibit 99.1) and power-of-attorney reference for signatures, evidencing coordinated compliance rather than operational governance shifts at ETHZilla.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The percentages reported in this Schedule 13G are based upon 160,176,168 Shares outstanding comprised of (i) 160,176,122 Shares outstanding as of September 19, 2025 (according to the issuer's Form 8-K/A as filed with the Securities and Exchange Commission on September 25, 2025), and (ii) 46 Shares issuable upon conversion of certain warrants held by affiliates of the reporting persons. Except as described in the preceding sentence, all Shares for the holdings of the reporting persons reported in this Schedule 13G are as of the opening of the market on September 25, 2025.


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Citadel Securities GP LLC
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:09/25/2025
Citadel Securities LLC
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:09/25/2025
Citadel Securities Group LP
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:09/25/2025
Citadel Advisors LLC
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:09/25/2025
Citadel Advisors Holdings LP
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:09/25/2025
Citadel GP LLC
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:09/25/2025
Kenneth Griffin
Signature:/s/ Seth Levy
Name/Title:Seth Levy, attorney-in-fact*
Date:09/25/2025

Comments accompanying signature: * Seth Levy is signing on behalf of Kenneth Griffin as attorney-in-fact pursuant to a power of attorney previously filed with the Securities and Exchange Commission, and hereby incorporated by reference herein. The power of attorney was filed as an attachment to a filing by Citadel Advisors LLC on Schedule 13G for Allakos Inc. on October 13, 2023.
Exhibit Information

Exhibit 99.1 - Joint Filing Agreement

FAQ

How many ETHZ shares do Citadel entities report owning?

The filing reports Citadel Securities-related entities beneficially own 5,643,440 shares (3.5% of the class).

What percentage of ETHZ does Kenneth Griffin report beneficially owning?

Kenneth Griffin is reported with shared beneficial ownership of 8,418,198 shares, equal to 5.3% of the outstanding shares.

What share count is the percentage based on in the Schedule 13G for ETHZ?

Percentages are based on 160,176,168 shares outstanding, which includes 46 shares issuable upon conversion of certain warrants held by affiliates.

When were the signatures on the Schedule 13G dated?

All signatures on the filing are dated September 25, 2025.

Does the filing indicate an intention to influence control of ETHZ?

No; the certification states the securities were not acquired and are not held for the purpose of changing or influencing control of the issuer.
ETHZilla Corporation

NASDAQ:ETHZ

ETHZ Rankings

ETHZ Latest News

ETHZ Latest SEC Filings

ETHZ Stock Data

72.63M
12.32M
Biotechnology
Finance Services
Link
United States
PALM BEACH